Metabolic effects of dialyzate glucose in chronic hemodialysis: results from a prospective, randomized crossover trial

Raimann, Jochen G; Kruse, Anja; Thijssen, Stephan; Kuntsevich, Viktoriya; Dabel, Pascal; Bachar, Mostafa; Diaz-Buxo, Jose A; Levin, Nathan W; Kotanko, Peter (2012). Metabolic effects of dialyzate glucose in chronic hemodialysis: results from a prospective, randomized crossover trial. Nephrology, dialysis, transplantation, 27(4), pp. 1559-68. Oxford: Oxford University Press 10.1093/ndt/gfr520

[img]
Preview
Text
gfr520.pdf - Published Version
Available under License Publisher holds Copyright.

Download (193kB) | Preview

There is no agreement concerning dialyzate glucose concentration in hemodialysis (HD) and 100 and 200 mg/dL (G100 and G200) are frequently used. G200 may result in diffusive glucose flux into the patient, with consequent hyperglycemia and hyperinsulinism, and electrolyte alterations, in particular potassium (K) and phosphorus (P). This trial compared metabolic effects of G100 versus G200.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension

UniBE Contributor:

Kruse, Anja

ISSN:

0931-0509

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:39

Last Modified:

05 Dec 2022 14:12

Publisher DOI:

10.1093/ndt/gfr520

PubMed ID:

21940484

Web of Science ID:

000302310700045

BORIS DOI:

10.7892/boris.15654

URI:

https://boris.unibe.ch/id/eprint/15654 (FactScience: 223065)

Actions (login required)

Edit item Edit item
Provide Feedback